Malaysia

Duopharma Biotech inks deal with govt to supply Russia’s Covid-19 vaccine

Work is subject to fulfilment of remaining condition precedent under supply agreements

Updated 5 years ago · Published on 01 Jun 2021 3:24PM

Duopharma Biotech inks deal with govt to supply Russia’s Covid-19 vaccine
Duopharma Biotech Bhd group managing director Leonard Ariff Abdul Shatar says the copany is fully committed and proud to be part of our nation’s inoculation programme. – AFP pic, June 1, 2021

KUALA LUMPUR – Duopharma Biotech Bhd’s wholly-owned subsidiary Duopharma (M) Sdn Bhd has signed with the Malaysian government, represented by the Health (MoH), to supply Russia’s Covid-19 vaccines.

The company has concluded execution of separate definitive supply agreements with the government and a subsidiary of the Russian Direct Investment Fund (RDIF) for the supply of 6.4 million doses of the Sputnik V vaccine.

In a filing with Bursa Malaysia today, Duopharma Biotech said the supply of the vaccine is subject to the fulfilment of the remaining condition precedent under the supply agreements, namely the approval of the vaccine by the Drug Control Authority of Malaysia, as well as other terms and conditions of supply.

Group managing director Leonard Ariff Abdul Shatar confirmed the company’s state of readiness.

“The Covid-19 pandemic has presented all Malaysians with extraordinary challenges, which we can only overcome through immediate collaboration on many fronts. Duopharma Biotech is fully committed and proud to be part of our nation’s inoculation programme,” he commented.

Sputnik V, developed by Russia’s Gamaleya National Research Institute of Epidemiology and Microbiology, has since been successfully registered in 68 countries across North and South America, the Middle East, Europe, Asia, and Africa.

Based on peer reviewed results of the second interim analysis Phase 3 published by one of the world’s oldest and most respected medical journals, The Lancet, Sputnik V’s efficacy has been confirmed at 91.6%.

It is one of only three vaccines in the world with an efficacy rating of over 90%, and no serious adverse events related to the vaccine were recorded, the group added. – Bernama, June 1, 2021

Related News

World / 4y

Sputnik’s effectiveness against Omicron to be tested within 10 days

World / 5y

WHO to restart approval process for Sputnik V

Business / 5y

UCrest inks master service agreement on Sputnik V jab production

World / 5y

Indonesia clears Sputnik V for use in Covid-19 fight

World / 5y

Vietnam makes test batch of Russia’s Sputnik V shot

World / 5y

Guatemala vexed over undelivered Russian Covid-19 vaccines

Spotlight

Malaysia

Bersama, Bersatu fail to win a seat in Melaka, face questions over political future

By Alfian Z.M. Tahir

Malaysia

African man apologises to Malaysians over machete attack on policeman

Malaysia

Two family members to be charged with murder of elderly man in Negeri Sembilan

Malaysia

Kuching student accused of attacking teacher with a deadly weapon sent for mental observation

People

Hans Isaac engaged to former Miss Universe Malaysia Francisca Luhong in Paris proposal

Malaysia

NS Exco: Palace weighs settlement proposals as court hearing postponed

Malaysia

Police hunt answers after 15-year-old girl shot in neck in Ranau

Malaysia

Missing 74-year-old windsurfer found dead off Tanjung Bungah

You may be interested

Malaysia

Retiree loses RM80k after WhatsApp investment scam demands RM50k to release profits

Malaysia

One-third of Melaka election candidates lose deposits

Malaysia

Hassan Karim summoned by Bukit Aman over viral poem on Najib's case

Malaysia

Melaka PRN: PH accepts Melaka setback after winning only four seats

Malaysia

Najib’s luxury lockup is set to become Malaysia’s hottest new tourist sensation

Malaysia

Foreign woman found dead by river in Bidor suspected murdered

Malaysia

Police hunt answers after 15-year-old girl shot in neck in Ranau

Malaysia

Amirudin: Selangor's RM489b economic ambition hinges on racial unity